WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002004644) ASPARTYLPROTEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/004644    International Application No.:    PCT/EP2001/007512
Publication Date: 17.01.2002 International Filing Date: 30.06.2001
Chapter 2 Demand Filed:    30.01.2002    
IPC:
C12N 9/52 (2006.01), C12N 9/64 (2006.01)
Applicants: BOEHRINGER INGELHEIM PHARMA KG [DE/DE]; 55216 Ingelheim/Rhein (DE) (For All Designated States Except US).
HAASS, Christian [DE/DE]; (DE) (For US Only).
STEINER, Harald [DE/DE]; (DE) (For US Only).
FECHTELER, Katja [DE/DE]; (DE) (For US Only).
KOSTKA, Marcus [DE/DE]; (DE) (For US Only)
Inventors: HAASS, Christian; (DE).
STEINER, Harald; (DE).
FECHTELER, Katja; (DE).
KOSTKA, Marcus; (DE)
Agent: LAUDIEN, Dieter; Boehringer Ingelheim GmbH CD Patents 55216 Ingelheim/Rhein (DE).
MAHLBACHER, Volker; Boehringer Ingelheim GmbH 55216 Ingelheim am Rhein (DE)
Priority Data:
100 32 709.5 07.07.2000 DE
Title (EN) ASPARTYLPROTEASE
(FR) ASPARTYL-PROTEASE
Abstract: front page image
(EN)The invention relates to proteins, peptides or aspartyl-proteases comprising specified consensus motifs and nucleic acids encoding said proteins, peptides or aspartyl-proteases. The invention further relates to methods of screening for substances capable of inhibiting said aspartyl-proteases, substances identifiable with said method and pharmaceutical compositions comprising said substances.
(FR)L'invention concerne des protéines, des peptides ou des aspartyl-protéases comportant des motifs de consensus spécifiés et des acides nucléiques codant lesdites protéines, peptides ou aspartyl-protéases. L'invention concerne également le dépistage de substances capables d'inhiber lesdites aspartyl-protéases, des substances identifiables grâce audit procédé et enfin, des compositions pharmaceutiques comprenant lesdites substances.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)